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Abstract Fibrosis is a chronic disorder affecting many or-
gans. A universal process in fibrosis is the formation of
myofibroblasts and the subsequent collagen deposition by
these cells. Transforming growth factor beta1 (TGFβ1) plays
a major role in the formation of myofibroblasts, e.g. by acti-
vating fibroblasts. Currently, no treatments are available to
circumvent fibrosis. Caffeic acid phenethyl ester (CAPE)
shows a broad spectrum of biological activities, including
anti-fibrotic properties in vivo inmice and rats. However, little
is known about the direct effects of CAPE on fibroblasts. We
have tested whether CAPE is able to suppress myofibroblast
formation and collagen formation of human dermal and lung
fibroblasts exposed to TGFβ1, and found that this was indeed
the case. In fact, the formation of myofibroblasts by TGFβ1
and subsequent collagen formation was completely abolished
by CAPE. The same was observed for fibronectin and
tenascin C. The lack of myofibroblast formation is likely
due to the suppression ofGLI1 andGLI2 expression by CAPE
because of diminished nuclear SMAD2/3 levels. Post-
treatment with CAPE after myofibroblast formation even re-
sulted in a partial reversal of myofibroblasts into fibroblasts
and/or reduction in collagen formation. Major discrepancies
Keywords Fibrosis . Collagen .Myofibroblasts . Caffeic
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Introduction
Caffeic acid phenethyl ester (CAPE) is a polyphenolic com-
pound with major anti-inflammatory, anti-fibrotic, anti-
oxidant and immune-modulatory properties (Tolba et al.
2013; Murtaza et al. 2014). CAPE is one of the active com-
pounds of honeybee propolis (Banskota et al. 2001), and has
been tested in vivo in a variety of fibrosis-related models in
rats and mice (Larki et al 2013; Tomur et al. 2011; Ogeturk
et al. 2005; Özyurt et al. 2004; Zhao et al. 2014; Chuang et al.
2014, 2015). These studies showed a protective effect of
CAPE, i.e. it attenuated the hallmark of fibrosis, namely ex-
cessive collagen deposition. Collagen is produced by
myofibroblasts (Goldsmith et al. 2014; Mallat et al. 2013),
and the in vivo studies indeed revealed a decrease in the
amount of alpha-smooth muscle actin (αSMA)-positive cells,
a marker that is widely used to detect myofibroblasts. How-
ever, little is known about the mechanisms behind the anti-
fibrotic properties of CAPE. Fibrosis is an end result of the
tissue repair process, and in this process a variety of inflam-
matory cells are involved, cells that secrete during the course
of healing various cytokines that stimulate myofibroblast for-
mation. Because of the many different inhibitory properties of
CAPE shown in vivo and in vitro, animal studies cannot re-
veal whether CAPE directly acts on fibroblasts. Thus, it is not
known if the decrease in myofibroblast numbers seen in vivo
is an effect of the anti-inflammatory or immuno-modulatory
properties of CAPE, or, alternatively, whether CAPE also di-
rectly affects the transformation of fibroblasts into
myofibroblasts.
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were seen between mRNA levels of collagen type I and cells
stained positive for collagen, underlining the need for protein
data in fibrosis studies to make reliable conclusions.
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To the best of our knowledge, only some fragmentary in-
formation is available on the direct effect of CAPE on fibro-
blasts regarding expression/synthesis of collagen type I and
αSMA. Murine lung fibroblasts (L929 cell line) exposed to
bleomycin exhibited increased levels of collagen production
(as measured by the collagen-specific amino acid hydroxypro-
line in the culture medium); this was not the case when the
cells were first pretreated with CAPE (Liu et al. 2013). On the
other hand, NIH 3T3 murine cells treated with CAPE showed
an increase of intracellular collagen levels (Song et al. 2008).
Hepatic stellate cells of Wistar rats exposed to CAPE showed
a decreased collagen type I gene expression (Zhao et al. 2003).
Finally, human nasal polyp-derived fibroblasts treated with
TGFβ1 showed increased gene and protein levels of αSMA
and collagen types I and III; this was inhibited by pretreating
the fibroblasts with CAPE (Chun et al. 2014).
Transforming growth factor beta1 (TGFβ1) is one of the
strongest pro-fibrotic cytokines (Ghosh et al. 2013; Yue et al.
2010). Fibroblasts stimulated with TGFβ1 rapidly transform
into myofibroblasts and start to produce large amounts of col-
lagen type I (Goldsmith et al. 2014; Mallat et al. 2013). In the
current study, we have stimulated human adult dermal (HDFa)
and human adult lung (HLFa) fibroblasts with TGFβ1 in the
presence or absence of CAPE, and investigated the expression
and/or synthesis of cytoskeletal components, collagen type I,
the collagen-modifying enzyme lysyl hydroxylase 2 (LH2),
and the transcription factors GLI1, GLI2, and SNAIL. In ad-
dition, we investigated whether myofibroblasts that are




HDFa [Caucasian, 20 years, CCD-1093Sk (ATCC® CRL-
2115™), ATCC, USA] and HLFa [Caucasian, 27 years,
CCD-19Lu (ATCC® CCL-210™), ATCC, USA] were cul-
tured in basal medium [= Eagle’s minimal essential medium
(BE12-662F; Lonza, Switzerland) containing 1 % l-glutamine
(Lonza), 1 % penicillin/streptomycin (Gibco Life Technolo-
gies, UK)] supplemented with 10 % fetal bovine serum (FBS)
(Thermo Scientific, USA). Passages 5–10 of HDFa and HLFa
were seeded with a density of 15,000 cells/cm2 in a Costar
12-well plate (for quantitative real time polymerase chain re-
action) or in a 48-well plate/8-well chamber slides (Corning,
USA; for immunofluorescence staining). After 72 h, fibro-
blasts were washed with phosphate-buffered saline (PBS),
starved overnight in basal medium supplemented with 0.5 %
FBS, treated for 30 min in basal medium supplemented with
0.17 mM L-ascorbic acid 2-phosphate magnesium salt
(A-8960; Sigma, USA) and 0.5 % FBS with/without CAPE
(5 μg/ml) (2743; Tocris, UK), and subsequently cultured for
48 h in basal medium supplemented with 0.17 mML-ascorbic
acid 2-phosphate magnesium salt and 0.5 % FBSwith/without
recombinant human TGFβ1 (10 ng/ml) (100-21; Peprotech,
UK) in the presence/absence of CAPE (5 μg/ml). In another
experiment, the fibroblasts that were starved overnight were
stimulated with basal medium supplemented with 0.17mML-
ascorbic acid 2-phosphate magnesium salt and 0.5 % FBS
with/without TGFβ1 (10 ng/ml) for 48 h, followed by a
post-treatment with basal medium supplemented with
0.17 mM L-ascorbic acid 2-phosphate magnesium salt and
0.5 % FBS with/without CAPE (5 μg/ml) for 24 h. Subse-
quently, whole-cell lysates (as obtained with FARB Buffer;
Favorgen Biotech, Taiwan) were used for quantitative real
time polymerase chain reaction (qRT-PCR). For immunoflu-
orescence studies, cells were washed with PBS and fixed with
methanol/acetone (1:1 ratio; Merck, Germany) for 5 min. The
CAPE compound was dissolved in absolute ethanol (vehicle)
at a concentration of 25 μg/μl. All cell culture protocols were
performed at 37 °C in a humidified 5 % CO2 environment.
RNA isolation, cDNA synthesis and qRT-PCR
Total RNA was isolated using the Favorgen RNA extraction
kit (Favorgen Biotech) according to the manufacturer’s proto-
col. The concentration and quality of RNAwas measured with
UV spectrophotometry (NanoDrop Technologies, Wilming-
ton, NC, USA). For the synthesis of cDNA, total RNA was
reverse transcribed with the First Strand cDNA synthesis kit
(Fermentas, Lithuania) according to the manufacturer’s proto-
col. Gene expression analysis was performed by means of
qRT-PCR in a 10-μl reaction mixture containing 10 ng cDNA,
SYBRGreenMaster Mix (Roche, USA), 6 μM forward prim-
er and 6 μM reverse primer (for primer sequences, see
Table 1). qRT-PCR was conducted in triplicate for each con-
dition in a 384-well plate at 95 °C for 15 s and 60 °C for 1 min
for 40 cycles using the ViiA 7 Real-Time PCR System (Ap-
plied Biosystems, USA). Data were analyzed with the ViiA 7
Real-Time PCR System Software (Applied Biosystems). All
mRNA data were normalized against the reference gene tyro-
sine 3-monooxygenase/tryptophan 5-monooxygenase activa-
tion protein, zeta isoform (YWHAZ).
Immunofluorescence staining
After methanol/acetone fixation, fibroblasts were washed and
incubated with primary antibodies (Table 2) diluted in PBS
containing 2 % bovine serum albumin (BSA) (K1106;
Sanquin, Netherlands) for 1 h at RT. After washing with
PBS, cells were incubated for 30 min at RT with biotinylated
secondary antibodies (Table 3) diluted in PBS containing 2 %
BSA for 30 min at RT. The cells were washed again and
incubated with streptavidin-CY3 (Invitrogen, USA) (1:100)
Table 1 List of primer sequences
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in PBS containing 1 % BSA and DAPI (1:10,000) for 30 min.
After washing with PBS, cell culture wells were mounted with
Citifluor (Agar Scientific, UK) and the staining pattern was
visualized with fluorescence imaging microscopy
(TissueFAXS; TissueGnostics, Austria). TissueFAXS data
was analyzed with the TissueQuest software as described pre-
viously (Mia et al. 2014).
Nuclear/cytoplasmic localization of SMAD2/3
HDFa and HLFa were cultured for 45 min in the presence of
CAPE alone, TGFβ1 alone, or TGFβ1 in combination with
CAPE. After treatment, cells were washed with ice-cold PBS
and fixed with methanol/acetone (1:1) for 5 min. Subsequent-
ly, cells were washed with PBS and incubated with polyclonal
goat anti-human to SMAD2/3 (AF3797; R&D, UK) diluted to
15 μg/ml in PBS containing 2 % bovine serum albumin
(BSA) (K1106; Sanquin, Netherlands) for 3 h at 4 °C. After
washing with PBS, cells were incubated with biotinylated
secondary an t ibody rabb i t an t i -goa t (6160-08 ;
SouthernBiotech, USA) diluted in PBS containing 2 % BSA
for 30 min at RT. The cells were washed again and incubated
for 30 min with streptavidin-CY3 (Invitrogen) (1:100) in PBS
containing 1 % BSA and DAPI (1:10,000). After washing
with PBS, cell culture wells were mounted with Citifluor
(Agar Scientific) and the staining pattern was visualized by
using confocal laser scanning microscopy (Leica TCS SP8;
Leica Microsystems, Germany).
Statistics
All mRNA and immunofluorescence data are presented as
mean±SEM for at least three independent experiments. Re-
sults were analysed with either one-way analysis of variance
(ANOVA) followed by Tukey’s post-test or two-tailed un-
paired t test analysis using Graph-Pad Prism v.5 (GraphPad
Software, USA). P<0.05 was considered to be statistically
significant.
Results
Basal levels of mRNA and protein in unstimulated HDFa
and HLFa
There were major differences in the basal expression levels
between HDFa and HLFa (Fig. 1). In HLFa, a higher expres-
sion was seen of ACTA2 (Fig. 1a), TAGLN (Fig. 1b), GLI1
(Fig. 1c), GLI2 (Fig. 1d), COL1A2 (Fig. 1f), and PLOD2
(Fig. 1g) compared to HDFa (a 4-fold, 5-fold, 10-fold, 2-fold,
2-fold and 4-fold difference, respectively). The basal expres-
sion ofCOL1A1was slightly, but significantly, lower in HLFa
compared to HDFa (Fig. 1e). The major differences in basal
Table 2 List of primary
antibodies used for
immunofluorescence analysis
Antigen (target protein) Antibody (dilution) Source (Cat. #, Company)
αSMA Mouse monoclonal IgG2a (1:100) M0851, Dako, Denmark
SM22α Polyclonal rabbit IgG (1:200) ab14106, Abcam, UK
Collagen type I Mouse monoclonal IgG1 (1:300) ab90395, Abcam, UK
LH2 Mouse polyclonal IgG (1:100) SAB1400213, Sigma, USA
Fibronectin Rabbit polyclonal IgG (1:400) ab6584, Abcam, UK
Tenascin C Mouse monoclonal IgG1 (1:100) ab6393, Abcam, UK
SMAD2/3 Polyclonal goat IgG (15μg/ml) AF3797, R&D, UK
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expression were also reflected in the protein stainings for
αSMA, SM22α, collagen I and LH2: the % cells that stained
positive for these proteins was always higher in HLFa than
HDFa (6-fold, 2-fold, 20-fold and 2.5-fold difference, respec-
tively) (Fig. 1h–s).
Effect of TGFβ1 and CAPE on nuclear localization
of SMAD2/3
Staining for SMAD2/3 showed a predominantly cytoplasmic
localization in HDFa (Fig. 2a–c) and HLFa (Fig. 2d–f), a
pattern that was dramatically shifted towards a nuclear local-
ization when the cells were stimulated with TGFβ1 (Fig. 2b,
e). CAPE clearly inhibited the nuclear translocation of
SMAD2/3 (Fig. 2c, f). These observations are in line with that
of Chuang et al. (2014, 2015).
Effect of TGFβ1 and CAPE on ACTA2 (αSMA)
In order to differentiate the fibroblasts into myofibroblasts, the
cells were stimulated for 48 h with TGFβ1. Both HDFa and
HLFa showed a major increase (>6-fold) in mRNA levels of
ACTA2 (encoding for the protein αSMA) (Fig. 3a, b), as was
the case for the number of cells stained positive for αSMA (>
10-fold increase) (Fig. 3e, i, k, l). Interestingly, the addition of
CAPE resulted in a suppression to baseline levels, both on an
mRNA level (Fig. 3a, b) and on a protein level (Fig. 3f, j–l).
Incubation of CAPE alone (thus without the addition of
TGFβ1) also suppressed the mRNA and protein level in
LFa, as these cells show, in contrast to HDFa, already at base-
line in some αSMA positive cells (Fig. 3a–d, g, h, k, l). Thus,
CAPE is able to inhibit the formation of TGFβ1-induced
αSMA stress fiber formation. CAPE is, in addition, able to
disrupt the already existing αSMA stress fibers seen in HLFa.
However, a post-treatment with CAPE did not result in a de-
crease of the TGFβ1-induced αSMA stress fibers in HLFa,
although a partial decrease was seen in HDFa under the same
conditions (Fig. 4a–f).
Effect of TGFβ1 and CAPE on TAGLN (SM22α)
Another cytoskeletal element, SM22α (encoded by TAGLN)
showed similar results. mRNAwas upregulated with TGFβ1
(HDFa: >10-fold; HLFa: 2-fold), an upregulation that was
suppressed by CAPE, but reaches baseline levels only in
HLFa (Fig. 5a, b). Stress fibers were upregulated with TGFβ1
as well, as indicated by a 2-fold increase in the % of cells that
stain positive for SM22α. CAPE suppressed the number of
positive cells to baseline levels, both for HDFa and HLFa
(Fig. 5c–l). CAPE alone had an effect only on the number of
positive cells that were present before TGFβ1 stimulation in
HDFa (Fig. 5c, d, k).
Effect of TGFβ1 and CAPE on collagen type I
expression/formation
We next investigated whether CAPE was able to inhibit col-
lagen type I expression/formation. TGFβ1 increased the ex-
pression ofCOL1A1 and COL1A2 in HFDa and HLFa (7- and
5-fold and 2- and 3-fold, respectively) (Fig. 6a–d). CAPE did
not inhibit the expression of COL1A1 in HDFa (Fig. 6a), and
increased the expression of COL1A2 >2-fold (Fig. 6b). In
contrast, CAPE inhibited the expression of COL1A1 in HLFa
to baseline levels (Fig. 6c), and slightly inhibited the expres-
sion of COL2A1 (but not to baseline levels) (Fig. 6d). At the
protein level, a different picture emerged: in both HDFa and
HLFa, the % cells stained positive for collagen type I was
dramatically reduced by CAPE. The few collagen-positive
cells of HLFa were present before TGFβ1 stimulation also
disappeared (Fig. 6e–n). Post-treatment with CAPE after
TGFβ1 stimulation resulted in a major decrease in collagen-
producing cells (HDFa: 5-fold decrease; HLFa: 2-fold de-
crease) (Fig. 7a–f).
Effect of TGFβ1 and CAPE on PLOD2 (LH2)
In fibrotic collagen, increased amounts are seen of cross-
links derived from hydroxylysine, a cross-link that is
catalyzed LH2 (van der Slot 2004, 2005a; Yamauchi
2012). mRNA of PLOD2, encoding for LH2, was 15-
fold and 4-fold upregulated after TGFβ1 stimulation in
HDFa and HLFa, respectively (Fig. 8a, b). Both cell types
reacted quite differently towards CAPE with respect to
PLOD2. In HDFa, PLOD2 mRNA levels were more than
10-fold upregulated compared to the mRNA levels seen
with TGFβ1 alone (Fig. 8a); in HLFa, this increase was
Table 3 List of secondary antibodies used for immunofluorescence analysis
Antigen (target protein) Biotinylated secondary antibody (dilution 1:100) Source (Cat. #, Company)
αSMA Goat-anti-mouse IgG2a 1080-08, SouthernBiotech, USA
SM22α and fibronectin Goat anti-rabbit IgG E0432, Dako, Denmark
Collagen type I and tenascin C Goat-anti-mouse IgG1 1071-08, SouthernBiotech, USA
LH2 Goat-anti-mouse IgG 1030-08, SouthernBiotech, USA
Smad2/3 Rabbit-anti-goat IgG 6160-08, SouthernBiotech, USA
<2-fold (Fig. 8b). Cells that were not stimulated with
TGFβ1 also showed an upregulation of PLOD2 when
incubated with CAPE: the induction was about 40-fold
in HDFa and 2-fold in HLFa (Fig. 8a, b). The increase
Fig. 1 Characterization of mRNA levels and protein synthesis as
observed in non-activated HDFa and HLFa. Fibroblasts were cultured
for 48 h in basal medium supplemented with 0.17 mM L-ascorbic acid
2-phosphate magnesium salt and 0.5% FBS in the absence of TGFβ1 and
CAPE. a–g mRNA levels of ACTA2, TAGLN, GLI1, GLI2, COL1A1,
COL1A2 and PLOD2 relative to the reference gene YWHAZ. h–o
Representative immunofluorescence stainings (upper panel) and p–s
quantification of the % of cells (lower panel) positive for αSMA,
SM22α, collagen type I and LH2. § Statistically significant towards
HDFa. Scale bar 100 μm
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Fig. 2 Effects of TGFβ1 and
CAPE on nuclear localization of
SMAD2/3. a–c HDFa and d–f
HLFa were cultured for 45 min in
the presence of TGFβ1 alone, or
TGFβ1 in combination with
CAPE (co-treatment). Fibroblasts
cultured in the presence of
TGFβ1 showed a strong nuclear
localization of SMAD2/3 (b, e),
whereas CAPE prevented the
TGFβ1-induced nuclear
translocation of SMAD2/3 (c, f).
Scale bar 25 μm
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of mRNA levels of PLOD2 without the presence of
TGFβ1 did not result in an increase of the % cells that
stained positive for LH2. The % LH2-positive cells in-
creased when stimulated with TGFβ1, and increased an
additional 1.5- to 2-fold in the presence of CAPE
(Fig. 8c–l).
Effect of TGFβ1 and CAPE on fibronectin (FN1)
and tenascin C (TNC) expression
Apart from collagen type I, we also tested the effect of CAPE
on the expression and synthesis of the extracellular matrix
proteins FN1 and TNC. TGFβ1 increased the expression of
Cell Tissue Res (2016) 363:775–789 781
Fig. 3 Effects of CAPE, TGFβ1 and TGFβ1+CAPE on ACTA2mRNA
levels and % αSMA-positive cells of HDFa and HLFa. Fibroblasts were
cultured for 48 h in the presence of CAPE alone, TGFβ1 alone, or
TGFβ1 in combination with CAPE (co-treatment). a, b mRNA levels
of ACTA2 relative to the reference gene YWHAZ and expressed as fold-
change compared to untreated control (i.e. the baseline level as provided
in Fig. 1). c–j Representative immunofluorescence stainings (upper
panel) and k, l quantification of the % of cells (lower panel) positive
for αSMA. * Statistically significant towards untreated control, and #
statistically significant for cells co-treated with TGFβ1+CAPE towards
TGFβ1-treated cells. Scale bar 100 μm
FN1 and TNC in HFDa and HLFa (Fig. 9a–d), an upregulation
that was suppressed to baseline levels by CAPE (Fig. 9a–d).
The same was seen with respect to the % cells that stained
positive for FN1 and TNC (data not shown).
Effect of TGFβ1 on GLI, GLI2 and SNAIL1
The presence of the transcription factors GLI1 and GLI2 are
required for myofibroblast formation. As expected, expression
ofGLI1 andGLI2was upregulated in the presence of TGFβ1:
>20-fold and 3-fold in HDFa, respectively (Fig. 10a, c), and
about 4-fold and 2.5-fold in HLFa, respectively (Fig. 10b, d).
The presence of CAPE during TGFβ1 stimulation had amajor
inhibitory effect on TGFβ1-induced upregulation ofGLI1 and
GLI2 (Fig. 10a–d). The transcription factor SNAIL1 was also
Fig. 4 Effects of post-treatment
of CAPE on cells treated with
TGFβ1 regarding the % αSMA-
positive cells of HDFa and HLFa.
Fibroblasts were cultured for 48 h
in the presence of TGFβ1,
followed by a post-treatment with
CAPE for 24 h. a–d
Representative
immunofluorescence stainings
(upper panel) and e, f
quantification of the % of cells
(lower panel) positive for αSMA.
# Statistically significant for cells
post-treated with CAPE towards
cells stimulated with TGFβ1
only. Scale bar 100 μm
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upregulated in the presence of TGFβ1: a 6-fold and 4-fold
induction was seen for HDFa and HLFa, respectively. Re-
markably, the presence of CAPE during TGFβ1 stimulation
resulted in an even higher upregulation of SNAIL1 in HDFa,
whereas a downregulation was seen in HLFa (Fig. 10e, f).
Discussion
A generally accepted model to mimic fibrotic events in vitro is
the stimulation of fibroblasts with TGFβ1, a cytokine that
shows strong pro-fibrotic properties. TGFβ1 stimulates the
synthesis of collagen, and also differentiates fibroblasts into
myofibroblasts. Although CAPE has been found to inhibit
fibrosis in vivo in rodents, very little is known about whether
collagen type I (as revealed by a major increase in the number
of cells stained positive for collagen), and that co-incubation
with CAPE entirely blocks both fibrotic hallmarks. Thus,
CAPE has strong anti-fibrotic properties towards fibroblasts.
Fig. 5 Effects of CAPE, TGFβ1 and TGFβ1+CAPE on TAGLNmRNA
levels and % SM22α-positive cells of HDFa and HLFa. Fibroblasts were
cultured for 48 h in the presence of CAPE alone, TGFβ1 alone, or
TGFβ1 in combination with CAPE (co-treatment). a, b mRNA levels
of TAGLN relative to the reference gene YWHAZ and expressed as fold-
change compared to untreated control (i.e. the baseline level as provided
in Fig. 1). c–j Representative immunofluorescence stainings (upper
panel) and k, l quantification of the % of cells (lower panel) positive
for SM22α. * Statistically significant towards untreated control, and #
statistically significant for cells co-treated with TGFβ1+CAPE towards
TGFβ1-treated cells. Scale bar 100 μm
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CAPE has direct anti-fibrotic properties on fibroblasts. Here,
we show that human dermal and lung fibroblasts treated with
TGFβ1 result in high numbers of myofibroblasts (i.e. cells
that show αSMA) and considerable protein production of
Fig. 6 Effects of CAPE, TGFβ1 and TGFβ1+CAPE on COL1A1 and
COL1A2mRNA levels and % collagen type I-positive cells of HDFa and
HLFa. Fibroblasts were cultured for 48 h in the presence of CAPE alone,
TGFβ1 alone, or TGFβ1 in combination with CAPE (co-treatment). a–d
mRNA levels of COL1A1 and COL1A2 relative to the reference gene
YWHAZ and expressed as fold-change compared to untreated control
(i.e. the baseline level as provided in Fig. 1). e–l Representative
immunofluorescence stainings (upper panel) and m, n quantification of
the % of cells (lower panel) positive for collagen type I. * Statistically
significant towards untreated control, and # statistically significant for
cells co-treated with TGFβ1+CAPE towards TGFβ1-treated cells.
Scale bar 100 μm
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Fig. 7 Effects of post-treatment
of CAPE on cells treated with
TGFβ1 regarding the % collagen
type I-positive cells of HDFa and
HLFa. Fibroblasts were cultured
for 48 h in the presence of
TGFβ1, followed by a post-
treatment with CAPE for 24 h. a–
d Representative
immunofluorescence stainings
(upper panel) and e, f
quantification of the % of cells
(lower panel) positive for
collagen type I. # Statistically
significant for cells post-treated
with CAPE towards cells
stimulated with TGFβ1 only.
Scale bar 100 μm
Cell Tissue Res (2016) 363:775–789 785
This statement can even be made despite the high increase in
PLOD2 mRNA levels (and LH2 protein synthesis). LH2 is a
major pro-fibrotic enzyme as it plays a role in the formation of
hydroxylysine-derived collagen cross-links (van der Slot et al.
2003, 2004, 2005a). Collagens containing this type of cross-
links are especially difficult to degrade (van der Slot et al.
2005b; Brinckmann et al. 2005). However, in the presence
of CAPE, hardly any collagen is produced.
We next investigated whether CAPE is able to reverse
myofibroblasts into fibroblasts, and if this is reflected in de-
creased expression levels of collagen. Remarkable differences
were seen between HDFa and HLFa: post-treatment with
CAPE showed a 2-fold decrease in αSMA-positive cells in
HDFa, whereas no decrease was seen in αSMA-positive cells
in HLFa. However, in both cases, a decrease is seen in the %
collagen-positive cells: a 5-fold decrease was observed for
HDFa, and a 2-fold decrease for HLFa. It is of importance to
note that CAPE thus has the capacity to partially reverse
myofibroblasts into fibroblasts (in the case of HDFa) and/or
partially inhibit collagen formation by myofibroblasts (in the
case of HLFa). Reversal of myofibroblasts to fibroblasts has
so far only been described for a few compounds (Yang et al.
2014). The data of HLFa show that a decrease in collagen
formation can occur despite unchanged levels ofαSMA stress
fibers. Indeed, the relationship between αSMA and collagen
is not 1:1, as it has been shown that αSMA-/- myofibroblasts
are still able to produce collagen (Takeji et al. 2006).
Since the presence of GLI1 and GLI2 is necessary for
myofibroblast formation, and CAPE is able to inhibit
myofibroblast formation as induced by TGFβ1, we wondered
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vwhether the co-incubation of TGFβ1 with CAPE has an
effect on GLI1 and GLI2 mRNA levels. Induction of GLI2
by TGFβ requires a nuclear presence of SMAD3 (Dennler
et al. 2007, 2009; Javelaud et al. 2011). Furthermore, GLI1
expression as conducted by TGFβ requires GLI2 (Dennler
et al. 2007). The decrease of GLI2 as seen in the presence of
CAPE is therefore likely to be related to the low levels of
SMAD3 in the nucleus, as observed by confocal laser
Fig. 8 Effects of CAPE, TGFβ1 and TGFβ1+CAPE onPLOD2mRNA
levels and % LH2-positive cells of HDFa and HLFa. Fibroblasts were
cultured for 48 h in the presence of CAPE alone, TGFβ1 alone, or
TGFβ1 in combination with CAPE (co-treatment). a, b mRNA levels
of PLOD2 relative to the reference gene YWHAZ and expressed as fold-
change compared to untreated control (i.e. the baseline level as provided
in Fig. 1). c–j Representative immunofluorescence stainings (upper
panel) and k, l quantification of the % of cells (lower panel) positive
for LH2. * Statistically significant towards untreated control, and #
statistically significant for cells co-treated with TGFβ1+CAPE towards
TGFβ1-treated cells. Scale bar 100 μm
Fig. 9 Effects of TGFβ1 and CAPE on fibronectin (FN1) and tenascin C
(TNC) gene expression. a–d Fibroblasts were cultured for 48 h in the
presence of CAPE alone, TGFβ1 alone, or TGFβ1 in combination with
CAPE (co-treatment) on mRNA levels of FN1 and TNC relative to the
reference gene YWHAZ and expressed as fold-change compared to
untreated control. * Statistically significant towards untreated control, #
statistically significant for cells co-treated with TGFβ1+CAPE towards
TGFβ1-treated cells
Cell Tissue Res (2016) 363:775–789 787
scanning microscopy. In addition, it is reasonable to assume
that the decrease of GLI1 in the presence of CAPE is a con-
sequence of diminished levels of GLI2, as GLI1 acts down-
stream of GLI2.
The binding of GLI1 and GLI2 to their DNA targets can be
blocked by the compound GANT61 (Lauth et al. 2007). Fibro-
blasts stimulated with TGFβ1 in the presence of GANT61 did
not show myofibroblast formation, collagen formation was not
upregulated, andαSMA stress fiber formation was not observed
(Cigna et al. 2012). In our studies with CAPE, we observed the
same, and it coincided with the suppression of GLI1 and GLI2
expression to baseline levels. It is therefore tempting to speculate
that the observations with CAPE regarding collagen type I and
αSMAcan at least be partially ascribed to the ability of CAPE to
suppress GLI1 and GLI2 expression. On the other hand, post-
treatment studies with GANT61 on TGFβ1-stimulated
fibroblasts showed a complete reversal of myofibroblasts into
fibroblasts, as revealed by an inhibition of collagen type I forma-
tion and the absence of αSMA stress fibers (although protein
levels of αSMA were hardly affected) (Cigna et al. 2012). In
Fig. 10 Effects of CAPE, TGFβ1 and TGFβ1+CAPE on GLI1, GLI2
and SNAIL1 mRNA levels of HDFa and HLFa. a–f Fibroblasts were
cultured for 48 h in the presence of CAPE alone, TGFβ1 alone, or
TGFβ1 in combination with CAPE (co-treatment) on mRNA levels of
GLI1, GLI2 and SNAIL1 relative to the reference gene YWHAZ and
expressed as fold-change compared to untreated control (i.e. the
baseline level as provided in Fig. 1). * Statistically significant towards
untreated control, # statistically significant for cells co-treated with
TGFβ1+CAPE towards TGFβ1-treated cells
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contrast, post-treatment with CAPE did not completely reverse
collagen production (both for HDFa and HLFa) and stress fiber
formation (for HDFa), or did not reverse stress fiber formation at
all (for HLFa). Thus, the post-treatment as seenwith CAPE does
not follow the same pattern of GANT61 post-treatment, which
can be explained by assuming that the remainingGLI1 andGLI2
levels are still (partially) capable of binding to their DNA targets.
Our data show that mRNA data of COL1A1 and COL1A2
cannot be used to predict collagen formation. In HDFa,
mRNA levels of COL1A1 and COL1A2 remained the same
and increased, respectively, when CAPE was added to the
TGFβ1, but the % cells stained positive for collagen de-
creased dramatically. The fold-decrease of COL1A1 and
COL2A1 in HLFa was also not in line with the fold decrease
in the % collagen-positive cells. Studies regarding the anti-
fibrotic properties of compounds should therefore always take
protein data as leading, not mRNA levels, at least with respect
to collagen. No conflicting data were observed between
mRNA levels and protein data of fibronectin and tenascin C.
Finally, there are major differences in the response of HDFa
andHLFa towards CAPE. For example, when CAPE is added to
TGFβ1, mRNA levels of COL1A2 are even further upregulated,
whereas a decrease is seen in HLFa. This was also the case for
SNAIL1. In addition, the magnitude of response can differ mark-
edly. mRNA levels of PLOD2were highly upregulated in HDFa
when CAPE was added to the culture medium, either alone or in
combination with TGFβ1, whereas a modest upregulation of
PLOD2 was seen in HLFa. It is well known that there is a high
heterogeneity among fibroblast strains, not only between tissues
but also within a single tissue (Chang et al. 2002; Sorrell and
Caplan 2009). It remains to be investigated whether our data
reflect tissue-specific or strain-specific differences; in either case,
CAPE was able to inhibit myofibroblast formation.
In conclusion, we show that CAPE has direct anti-fibrotic
effects on fibroblasts: it is able to fully counteract the TGFβ1-
induced myofibroblast formation and concomitant collagen
formation, and is even able to partially reverse myofibroblasts
into fibroblasts and/or partially reverse collagen formation.
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